PaulJanssenFuturelab

@FuturelabLeiden

We train professionals. Ready to go online and on-campus?

Leiden, The Netherlands
Vrijeme pridruživanja: siječanj 2017.
Rođen/a 30. siječnja

Tweetovi

Blokirali ste korisnika/cu @FuturelabLeiden

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FuturelabLeiden

  1. 1. velj

    Curious about Question Based Clinical Development? Sign up for a free demo of the online course. The next online course starts on March 2nd.

    Poništi
  2. proslijedio/la je Tweet
    Prikaži ovu nit
    Poništi
  3. 29. sij

    For everyone interested in clinical development: Visit Albinusnet for an article about the recent Nature Biotech paper detailing a Question Based approach to optimize clinical development

    Poništi
  4. 24. sij

    Curious about Question Based Clinical Development? Sign up for a free demo of the online course.

    Poništi
  5. 21. sij

    Published in Nature Biotechnology: Integrating scientific considerations into R&D project valuation. Join the blended course Clinical Development to learn more. Start date: March 2.

    Poništi
  6. proslijedio/la je Tweet
    27. pro 2019.

    The view of project valuation as taught in

    Poništi
  7. 16. sij

    See this month’s Nature Biotechnology issue for our paper describing Question Based Clinical Development: a new approach to define the most optimal route to develop new medical interventions such as drugs and medical devices.

    Poništi
  8. 16. sij

    Honored to be featured in this month's Nature Biotech with our paper about Question Based Clinical Development

    Poništi
  9. proslijedio/la je Tweet
    9. lis 2019.

    Tromgeroffel... De winnaars van een scholarship voor de blended course clinical development bij zijn Gerard Boink, (PacingCure BV) en Sarah Triest (Confo Therapeutics). De cursus is inmiddels gestart. Veel leerplezier!

    Poništi
  10. This year's winners of the start-up scholarships are: Gerard Boink and Sarah Triest. Janssen Campus the Netherlands has made these scholarships available to allow young start ups to join the Clinical Development course.

    Poništi
  11. We now have scholarships for biomedical start-ups planning to run their first FIH clinical trial within 1-1.5 y. Join the Clinical Development course for FREE and take advantage of mentorship to write up your clinical trial proposal. Deadline: October 3.

    Poništi
  12. Laurel Schunselaar (LUMC) is the winner of the Paul Janssen Futurelab Nomination Letter 2019 for a half million grant from ZonMw

    Poništi
  13. Featured in Bionews: What can you expect from the Clinical Development course? !

    Poništi
  14. Thank you for a nice Leiden International (Bio)Medical Student Conference. The atmosphere was relaxed and buzzing!

    Poništi
  15. The Janssen scholarship is now closed and applications are being reviewed as we speak. Candidates from Dutch UMCs and NKI/AVL can still apply for a scholarship until March 11!

    Poništi
  16. proslijedio/la je Tweet
    12. velj 2019.

    Meet us next Thursday at Innovation for Health! Learn about the latest developments in the field of during our morning session our visit our booth. Looking forward to seeing you in Rotterdam!

    Poništi
  17. One week left to apply for the Janssen Pharmaceutica scholarship. Application closes on February 18!

    Poništi
  18. First comes winter, then comes... a new course! Start March 25 - **

    Poništi
  19. Scholarships for Biomedical ! has made available 2 scholarships for the blended course Clinical Development. Learn about Question Based Clinical Development and receive guidance for the development of a first-in-man trial

    Poništi
  20. Meet part of our team at the event in London (18-20 Dec). In collaboration with we are presenting TRC2.0: an interactive tool for medical and biopharmaceutical students.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·